| 000 | 01145 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517234630.0 | ||
| 264 | 0 | _c20190906 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1539-0829 | ||
| 024 | 7 |
_a10.1007/s11892-018-1043-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBahtiyar, Gül | |
| 245 | 0 | 0 |
_aCardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes. _h[electronic resource] |
| 260 |
_bCurrent diabetes reports _c08 2018 |
||
| 300 |
_a92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 |
_aCardiovascular System _xpathology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 700 | 1 | _aPujals-Kury, Jean | |
| 700 | 1 | _aSacerdote, Alan | |
| 773 | 0 |
_tCurrent diabetes reports _gvol. 18 _gno. 10 _gp. 92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11892-018-1043-z _zAvailable from publisher's website |
| 999 |
_c28792470 _d28792470 |
||